Home > Insider Trading > Filing (0000899243-22-025091)

Filing Details

Accession Number:: 0000899243-22-025091
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-07-05 18:42:03
Reporting Period:: 2022-06-30

Accepted Time:: 2022-07-05 18:42:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1837014	Smartrent Inc.	SMRT	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1295402	T Enrique Salem	C/O Bain Capital Venture Investors, Llc 200 Clarendon Street Boston MA 02116	No	No	Yes	No
1309469	Bain Capital Venture Investors, Llc	200 Clarendon Street Boston MA 02116	No	No	Yes	No
1708763	Ajay Agarwal	C/O Bain Capital Venture Investors, 200 Clarendon Street Boston MA 02116	No	No	Yes	No
1756817	Bain Capital Venture Fund 2019, L.p.	200 Clarendon Street Boston MA 02116	No	No	Yes	No
1758684	Bcv 2019-Md Primary, L.p.	200 Clarendon Street Boston MA 02116	No	No	Yes	No
1859012	Bcip Venture Associates Ii-B, Lp	200 Clarendon Street Boston MA 02116	No	No	Yes	No
1859026	Bcip Venture Associates Ii, L.p.	200 Clarendon Street Boston MA 02116	No	No	Yes	No
1859037	Bain Capital Venture Investors 2019, Llc	200 Clarendon Street Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2022-06-30	250,000	$4.41	21,722,649	No	4	S	Indirect	See footnotes
Class A Common Stock	Disposition	2022-07-01	1,000	$4.49	21,721,649	No	4	S	Indirect	See footnotes
Class A Common Stock	Disposition	2022-07-05	229,000	$4.49	21,492,649	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes

Footnotes

Bain Capital Venture Investors, LLC ("BCVI") is the manager of Bain Capital Venture Investors 2019, LLC ("BCVI 2019"), which is the general partner of each of Bain Capital Venture Fund 2019, L.P. ("BCV Fund 2019") and BCV 2019-MD Primary, L.P. ("BCV MD Primary"). As a result, BCVI 2019 may be deemed to share voting and dispositive power with respect to the shares of the Issuer's Class A Common Stock held by BCV Fund 2019 and BCV MD Primary. BCVI 2019 disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. On June 30, 2022, July 1, 2022 and July 5, 2022, BCV Fund 2019 sold 217,683, 871 and 199,397 shares of the Issuer's Class A Common Stock, respectively, and BCV MD Primary sold 8,372, 33 and 7,669 shares of the Issuer's Class A Common Stock, respectively. Following such sales, BCV Fund 2019 and BCV MD Primary held 18,714,300 and 719,784 shares of the Issuer's Class A Common Stock, respectively.
Boylston Coinvestors, LLC is the general partner of each of BCIP Venture Associates II, L.P. ("BCIP Venture II") and BCIP Venture Associates II-B, LP ("BCIP Venture II-B" and, together with BCV Fund 2019, BCV MD Primary and BCIP Venture II, the "Bain Capital Venture Entities"). On June 30, 2022, July 1, 2022 and July 5, 2022, BCIP Venture II sold 22,146, 89 and 20,286 shares of the Issuer's Class A Common Stock, respectively, and BCIP Venture II-B sold 1,799, 7 and 1,648 shares of the Issuer's Class A Common Stock, respectively. Following such sales, BCIP Venture II and BCIP Venture II-B held 1,903,892 and 154,673 shares of the Issuer's Class A Common Stock, respectively.
The governance, investment strategy and decision-making process with respect to the investments held by the Bain Capital Venture Entities is directed by the Executive Committee of BCVI, which consists of Enrique Salem and Ajay Agarwal. As a result, BCVI and Messrs. Salem and Agarwal may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Venture Entities. BCVI and Messrs. Salem and Agarwal disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.30 to $4.525, inclusive. The reporting persons undertake to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (4) and (5) to this Form 4.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.23 to $4.66, inclusive.